4Kalinski P, Muthuswamy R, Urban J. Dendritic cells in cancer immunotherapy., vaccines and combination immunotherapies[J2. Expert Rev Vaccines, 2013,12 : 285-295. 被引量：1
5Houtenbos I, Westers TM, Ossenkoppele GJ, et al. Leukemia-derived dendritic cells: towards clinical vac- cination protocols in acute myeloid leukemia l-J2. Haematologica, 2006,91 : 348- 355. 被引量：1
6Jarnjak-Jankovic S, Hammerstad H, Saeboe-I.arssen S,et al. A full scale comparative study of methods for.generation of functional Dendritic cells for use as cancer vaccines[J]. BMC Cancer, 2007,7 : 119 - 119. 被引量：1
7Qian J,Xie J,Hong S,et al. Dickkopf-1 (DKK1) is awidely expressed and potent tumor-associated antigen in multiple myeloma I-J]. Blood, 2007, 110:1587 - 1594. 被引量：1
8Lee JJ, Park MS,Park JS, et al. Induction of leukemic- cell-specific cytotoxic T lymphocytes by autologous monocyte-derived dendritic cells presenting leukemic cell antigens[J]. J Clin Apher,2006,21: 188- 194. 被引量：1
9Gardner TA, Elzey BD, Hahn NM. Sipuleucel-T (Provenge) autologous vaccine approved for treat- ment of men with asymptomatic or minimally symp- tomatic castrate-resistant metastatic prostate cancer I-J]. Hum Vaccin Immunother, 2012,8: 534- 539. 被引量：1
10Lou Y, Liu C, Kim GJ, et al. Plasmacytoid dendritic cells synergize with myeloid dendritic cells in the in- duction of antigen-specific antitumor immune respon- ses[J]. J Immunol, 2007,178 : 1534-1541. 被引量：1
